LLY

989.23

-1.47%↓

JNJ

227.42

+0.29%↑

ABBV

209.43

-0.47%↓

UNH

387.03

-1.68%↓

AZN

184.21

+1.43%↑

LLY

989.23

-1.47%↓

JNJ

227.42

+0.29%↑

ABBV

209.43

-0.47%↓

UNH

387.03

-1.68%↓

AZN

184.21

+1.43%↑

LLY

989.23

-1.47%↓

JNJ

227.42

+0.29%↑

ABBV

209.43

-0.47%↓

UNH

387.03

-1.68%↓

AZN

184.21

+1.43%↑

LLY

989.23

-1.47%↓

JNJ

227.42

+0.29%↑

ABBV

209.43

-0.47%↓

UNH

387.03

-1.68%↓

AZN

184.21

+1.43%↑

LLY

989.23

-1.47%↓

JNJ

227.42

+0.29%↑

ABBV

209.43

-0.47%↓

UNH

387.03

-1.68%↓

AZN

184.21

+1.43%↑

Home・Akcijų sąrašas・CVS Health Corp.

CVS Health Corp.

Atidarymo kaina

SektoriusSveikatos priežiūra

94.93 -0.96

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

94.74

Max

95.92

Pagrindiniai rodikliai
By Trading Economics
Pajamos	14M 3B
Pardavimai	-5.3B 100B
P/E Sektoriaus vid.	40.447 51.415
Pelnas, tenkantis vienai akcijai	2.57
Dividendų pajamingumas	2.94
Pelno marža	2.944
Darbuotojai	219,000
EBITDA	2.5B 5.8B

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+6.74% upside

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	2.94% 2.34%
Kitas uždarbis	2026-07-30
Kitas dividendų mokėjimo data	2026-07-31
Kita Ex Dividend data	2026-07-21

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	13B 118B
Ankstesnė atidarymo kaina	95.89
Ankstesnė uždarymo kaina	94.93

Naujienos nuotaikos

By Acuity

30%

70%

55 / 345 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

65.92 / 68.28 Palaikymas ir pasipriešinimas

CVS Health Corp. Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-05-13 20:00; UTC

Įsigijimai, susijungimai, perėmimai

Omnicare Receives Court Approval for Sale of Business to GenieRx

2026-05-06 11:02; UTC

Uždarbis

CVS Health Stock Jumps After Earnings. What's Encouraging Wall Street. -- Barrons.com

2026-05-06 10:47; UTC

Uždarbis

CVS Health Stock Jumps After Earnings. What's Encouraging Wall Street. -- Barrons.com

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Net $2.94B >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Front Store Same-Store Sales Up 1.2% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Sees FY Adj EPS $7.30-Adj EPS $7.50 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Health Services Segment Revenue Up 11.0% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Sees FY Net $8.03B-Net $8.29B >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Sees FY EPS $6.24-EPS $6.44 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q EPS $2.30 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Healthcare Benefits Segment Revenue Up 3.3% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Adj EPS $2.57 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Health Care Benefits Segment's 1Q Medical Benefit Ratio 84.6% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Updates 2026 Cash Flow From Operations Guidance to at Least $9.5B From at Least $9B >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Increasing Full-Year 2026 EPS, Adj EPS and Cash Flow From Operations Guidance to Reflect Increases in Health Care Benefits and Pharmacy & Consumer Wellness Segments >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Prescriptions Filled Rose 3.6% on 30-Day Equivalent Basis >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health: 1Q Adjusted EPS Rose Primarily Due to Improved Adjusted Operating Income in Health Care Benefits Segment >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health: Maintaining a Cautious View for Remainder of the Year in Light of Continued Elevated Cost Trends and Potential for Macro Headwinds >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Healthcare Benefits Segment Revenue Up 3.3% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health: 1Q Health Services Segment Rev Rose Primarily Driven by Pharmacy Drug Mix and Brand Inflation, Partially Offset by Continued Pharmacy Client Price Improvements >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health: 1Q Health Care Benefits Segment Rev Rose Primarily Driven by Increase in Govt Business, Partially Offset by Decline as Result of CO's Exit of Individual Exchange Business in 2026 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue Flat >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health: 1Q Adj. Operating Income $5.15B >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Same-Store Prescription Volume Rose 6.8% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue $31.99B >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Front Store Same-Store Sales Up 1.2% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Raises 2026 View To EPS $6.24-EPS $6.44 Vs Prior View $5.94-$6.14 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q Pharmacy Same-Store Sales Up 3.1% >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health Raises 2026 View To Adj EPS $7.30-Adj EPS $7.50 Vs Prior View $7-$7.20 >CVS

2026-05-06 10:30; UTC

Uždarbis

CVS Health 1Q EPS $2.30 >CVS

Akcijų palyginimas

Kainos pokytis

CVS Health Corp. Prognozė

Kainos tikslas

By TipRanks

6.74% į viršų

12 mėnesių prognozė

Vidutinis 102.35 USD 6.74%

Aukščiausias 111 USD

Žemiausias 92 USD

Remiantis 17 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines CVS Health Corp. kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

17 ratings

Pirkti

Laikyti

Parduoti

Remiantis 17 analitikų, pateikusių CVS Health Corp. akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

65.92 / 68.28Palaikymas ir pasipriešinimas

All events are bullish.

Bullish events outweigh bearish events.

Rinkos nuotaikos

By Acuity

55 / 345 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.